These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 1339195)
1. Oliver memorial lecture. Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity. Tovey LA Transfus Med; 1992 Jun; 2(2):99-109. PubMed ID: 1339195 [No Abstract] [Full Text] [Related]
2. Treatment options for the fetus with alloimmune hemolytic disease. Bowman JM Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630 [No Abstract] [Full Text] [Related]
3. The history of rhesus prophylaxis with anti-D. Wegmann A; Glück R Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551 [No Abstract] [Full Text] [Related]
5. Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype. Aref K; Boctor FN; Pande S; Uehlinger J; Manning F; Eglowstein M; Mallozzi A; Bebbington M; Weinberg G; Rosen O; Raab C; Brion LP J Perinatol; 2002 Dec; 22(8):667-8. PubMed ID: 12478452 [TBL] [Abstract][Full Text] [Related]
6. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17. Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861 [TBL] [Abstract][Full Text] [Related]
7. RhD hemolytic disease of the newborn. Bowman JM N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715 [No Abstract] [Full Text] [Related]
8. The experience and effectiveness of the Nova Scotia Rh program, 1964-84. Baskett TF; Parsons ML; Peddle LJ CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235 [TBL] [Abstract][Full Text] [Related]
9. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Kumpel BM Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599 [No Abstract] [Full Text] [Related]
10. Severe hemolytic disease of the newborn due to anti-Cw. Byers BD; Gordon MC; Higby K Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563 [TBL] [Abstract][Full Text] [Related]
12. Management of neonatal Rh disease. Peterec SM Clin Perinatol; 1995 Sep; 22(3):561-92. PubMed ID: 8521682 [TBL] [Abstract][Full Text] [Related]
13. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis? Chitkara U; Bussel J; Alvarez M; Lynch L; Meisel RL; Berkowitz RL Obstet Gynecol; 1990 Oct; 76(4):703-8. PubMed ID: 2120641 [TBL] [Abstract][Full Text] [Related]
14. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy. Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141 [TBL] [Abstract][Full Text] [Related]
15. Allo-immunization during pregnancy. Clinical results from 1983 to 1989 in a Scandinavian university hospital. Belfrage P; Thomassen P; Floberg J; Akerblom O; Broberger U Acta Obstet Gynecol Scand; 1992 May; 71(4):273-7. PubMed ID: 1322620 [TBL] [Abstract][Full Text] [Related]
19. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given? Bowman JM Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267 [TBL] [Abstract][Full Text] [Related]
20. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists. Urbaniak SJ Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402 [No Abstract] [Full Text] [Related] [Next] [New Search]